# Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overcoming-erlotinib-resistance-in-i-egfr-i-mutation-positive-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kunio Okamoto,Isamu Okamoto,Erina Hatashita,Kiyoko Kuwata,Haruka Yamaguchi,Aya Kita,Kentaro Yamanaka,Mayumi Ono,Kazuhiko Nakagawa |
| Citations | 68 |
| DOI | 10.1158/1535-7163.mct-11-0638 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2149943814 |
| PMID | 22075159 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cell death mechanisms and regulation](https://scholariq.org/topics/cell-death-mechanisms-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.